Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazines. 2021

Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
School of Chemistry, The University of Melbourne, Parkville, VIC 3010, Australia.

Novel 3,3'-disubstituted-5,5'-bi(1,2,4-triazine) compounds with potent in vitro activity against Plasmodium falciparum parasites were recently discovered. To improve the pharmacokinetic properties of the triazine derivatives, a new structure-activity relationship (SAR) investigation was initiated with a focus on enhancing the metabolic stability of lead compounds. These efforts led to the identification of second-generation highly potent antimalarial bis-triazines, exemplified by triazine 23, which exhibited significantly improved in vitro metabolic stability (8 and 42 μL/min/mg protein in human and mouse liver microsomes). The disubstituted triazine dimer 23 was also observed to suppress parasitemia in the Peters 4-day test with a mean ED50 value of 1.85 mg/kg/day and exhibited a fast-killing profile, revealing a new class of orally available antimalarial compounds of considerable interest.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010962 Plasmodium berghei A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni. Plasmodium bergheus,berghei, Plasmodium
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
July 2007, Journal of Zhejiang University. Science. B,
Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
May 2019, Future medicinal chemistry,
Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
October 2011, Journal of medicinal chemistry,
Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
March 1980, Journal of pharmaceutical sciences,
Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
June 2013, Chemistry (Weinheim an der Bergstrasse, Germany),
Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
March 2007, Bioorganic & medicinal chemistry letters,
Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
August 2011, Organic letters,
Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
September 2017, European journal of medicinal chemistry,
Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
October 2010, Bioorganic & medicinal chemistry letters,
Daniel L Priebbenow, and Mitch Mathiew, and Da-Hua Shi, and Jitendra R Harjani, and Julia G Beveridge, and Marina Chavchich, and Michael D Edstein, and Sandra Duffy, and Vicky M Avery, and Robert T Jacobs, and Stephen Brand, and David M Shackleford, and Wen Wang, and Longjin Zhong, and Given Lee, and Erin Tay, and Helena Barker, and Elly Crighton, and Karen L White, and Susan A Charman, and Amanda De Paoli, and Darren J Creek, and Jonathan B Baell
May 2017, Chemical science,
Copied contents to your clipboard!